Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorg Michels

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial-There is No Significant Reduction in Death (Yet)Jorg Michels
The International Journal of Biochemistry & Cell Biology|October 12, 2004
Mcl-1Jorg Michels, Peter W M Johnson, Graham Packham
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 14, 2011
Synchronous metastatic seminoma and primary retroperitoneal ganglioneuroma: case report and literature reviewJorg Michels, Nicholas Van Der Westhuizen, Alison Ross
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literatureJorg Michels, Sean Barbour, Douglas Cavers, et al.
Cancer|February 4, 2006
First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter?Jorg Michels, Trina Montemurro, Nevin Murray, et al.
British Journal of Haematology|February 21, 2006
Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphomaJorg Michels, Vipul Foria, Ben Mead, et al.
Oncogene|May 4, 2004
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavageJorg Michels, Jason W O'Neill, Claire L Dallman, et al.
Haematologica|December 24, 2002
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patientsPier Luigi Zinzani, Maurizio Martelli, Marilena Bertini, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial-There is No Significant Reduction in Death (Yet)Jorg Michels
The International Journal of Biochemistry & Cell Biology|October 12, 2004
Mcl-1Jorg Michels, Peter W M Johnson, Graham Packham
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 14, 2011
Synchronous metastatic seminoma and primary retroperitoneal ganglioneuroma: case report and literature reviewJorg Michels, Nicholas Van Der Westhuizen, Alison Ross
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literatureJorg Michels, Sean Barbour, Douglas Cavers, et al.
Cancer|February 4, 2006
First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter?Jorg Michels, Trina Montemurro, Nevin Murray, et al.
British Journal of Haematology|February 21, 2006
Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphomaJorg Michels, Vipul Foria, Ben Mead, et al.
Oncogene|May 4, 2004
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavageJorg Michels, Jason W O'Neill, Claire L Dallman, et al.
Haematologica|December 24, 2002
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patientsPier Luigi Zinzani, Maurizio Martelli, Marilena Bertini, et al.
Pageof 1